CompoAtlas

Prime Health Ginkgo Biloba 60 mg

Prime Health Ginkgo Biloba 60 mg, NPN 80027698: natural health product licensed in Canada. Medicinal ingredients: Ginkgo biloba.

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ginkgo biloba

Source : Feuille

Potency : 6 % Terpene lactones

0.06 gNot calculated
Ginkgo biloba

Source : Feuille

Potency : 24 % Flavonoid glycosides

60 mgNot calculated
Ginkgo biloba

Source : Feuille

Extraction ratio : 50:1

Dry plant equivalent : 3 g

Not specifiedNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Gélatine, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsuleminimum: 2 days ; maximum: 3 days

Uses authorised in Canada

Helps to enhance cognitive function in adults. Helps to enhance memory in adults.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No warning text available in the imported data.

Product record

Other names
Canda Ginkgo Biloba 60 mg, Maple Health Ginkgo Biloba 60 mg, Maple leaf Ginkgo Biloba 60 mg, Vital Source Ginkgo Biloba 60 mg, Vital Source Ginkgo Biloba 60mg
Licence holder
Prime Health Ltd. (Canada Global Life Sciences)
NPN or DIN-HM
80027698
Status
Active licence
Licence date
19 October 2011
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80027698

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Prime Health Ginkgo Biloba 60 mg (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80027698-prime-health-ginkgo-biloba-60-mg, updated 19 October 2011.

Enter to analyse, Shift+Enter for a new line